About us Products The science Career Social responsibility Production Press center Contacts RU RU +7 (812) 380-49-33 St. Petersburg +7 (495) 992-66-28 Moscow biocad@biocad.ru or write us an email one 2 3 four ALGERON® IN GEORGIA 09/18/2014 On September 5 and 6, 2014, the First Transcaucasian International Conference on current problems of Liver diseases was held in Tbilisi. The main topics of discussion were: the problem of the spread of hepatitis C, B and D, complications of liver cirrhosis, hepatocellular carcinoma and issues related to liver transplantation. The conference was organized with the support of the Armenian Hepatological Forum and the Georgian Association of Hepatology, and the Russian pharmaceutical company BIOCAD became one of the premium sponsors. Russia at this conference was represented by Professor, Doctor of Medical Sciences. Marina Maevskaya, Vice President of the Russian Society for the Study of the Liver. Her report was devoted to the real figures of the incidence of hepatitis C in the megalopolis of the Russian Federation, as well as to the currently available options for CHC therapy in Russia, which are not yet available in a number of countries of the Transcaucasian region. Thus, three preparations of pegylated interferon alfa are available in Russia, including the new Russian original drug Algeron®, as well as 3 drugs from the group of protease inhibitors, incl. second generation drug - simeprevir. Protease inhibitors are used in combination with any of the listed peginterferons and ribavirin to increase the effectiveness of CHC therapy in patients with 1 genotype of the virus. A new domestic antiviral drug for the treatment of viral hepatitis C Algeron® was registered in February 2013, and appeared on the market in July of the same year. The first Russian-made drug based on pegylated interferon has proven itself well even at the stage of clinical trials, now it demonstrates high results of virological response in real clinical practice. That is why it is proud to be represented at international medical conferences such as EASL, AASLD and TICL. Back to news list → © 2012 - 2015 CJSC "BIOCAD". All rights reserved. Website development "Legion"